This is a Validated Antibody Database (VAD) review about green monk.. CD44, based on 24 published articles (read how Labome selects the articles), using CD44 antibody in all methods. It is aimed to help Labome visitors find the most suited CD44 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Knockout validation
Invitrogen
mouse monoclonal (156-3C11)
  • immunocytochemistry knockout validation; human; 2 ug/ml; loading ...; fig 1d
  • western blot knockout validation; human; 1:1000; loading ...; fig 1f, 1s1b, 3e
  • immunohistochemistry - paraffin section; human; loading ...; fig 4s2b
Invitrogen CD44 antibody (Thermo Fisher, MA513890) was used in immunocytochemistry knockout validation on human samples at 2 ug/ml (fig 1d), in western blot knockout validation on human samples at 1:1000 (fig 1f, 1s1b, 3e) and in immunohistochemistry - paraffin section on human samples (fig 4s2b). elife (2022) ncbi
Invitrogen
mouse monoclonal (156-3C11)
  • immunocytochemistry knockout validation; human; 2 ug/ml; loading ...; fig 1d
  • western blot knockout validation; human; 1:1000; loading ...; fig 1f, 1s1b, 3e
  • immunohistochemistry - paraffin section; human; loading ...; fig 4s2b
Invitrogen CD44 antibody (Thermo Fisher, MA513890) was used in immunocytochemistry knockout validation on human samples at 2 ug/ml (fig 1d), in western blot knockout validation on human samples at 1:1000 (fig 1f, 1s1b, 3e) and in immunohistochemistry - paraffin section on human samples (fig 4s2b). elife (2022) ncbi
mouse monoclonal (MEM-263)
  • flow cytometry; human; fig 3
Invitrogen CD44 antibody (Thermo Scientific, MEM-263) was used in flow cytometry on human samples (fig 3). Antioxidants (Basel) (2021) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:250; loading ...; fig 3h
  • western blot; human; 1:250; loading ...; fig 5d
Invitrogen CD44 antibody (Thermo Fisher, MA5-13890) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 3h) and in western blot on human samples at 1:250 (fig 5d). J Neuroinflammation (2020) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:100; fig 8i
Invitrogen CD44 antibody (Invitrogen, MA5-13890) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 8i). Nat Commun (2019) ncbi
mouse monoclonal (156-3C11)
  • immunocytochemistry; human; loading ...; fig 2e
In order to find RE1 silencing transcription factor regulates epithelial-mesenchymal transition and neuroendecrin cell stemness acquisition in hormone-refractory prostate cancer, Invitrogen CD44 antibody (Thermo Scientific, MA5-13890) was used in immunocytochemistry on human samples (fig 2e). Sci Rep (2017) ncbi
mouse monoclonal (156-3C11)
  • blocking or activating experiments; human; loading ...; fig 4c
In order to implicate myeloid differentiation factor-2 as the high-affinity soluble CD83 binding partner, Invitrogen CD44 antibody (Invitrogen, 156-3c11) was used in blocking or activating experiments on human samples (fig 4c). J Immunol (2017) ncbi
mouse monoclonal (156-3C11)
  • flow cytometry; human; fig 2b
In order to explore how the CD74/CD44 MIF receptor contributes to rheumatoid arthritis, Invitrogen CD44 antibody (ThermoFisher Scientific, 156-3c11) was used in flow cytometry on human samples (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:800; loading ...; fig 2b
Invitrogen CD44 antibody (Thermo Fisher, MA5-13890) was used in immunohistochemistry - paraffin section on human samples at 1:800 (fig 2b). Mol Med Rep (2016) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 3a
In order to propose that CD44+/24- is a good prognostic marker for breast cancer, Invitrogen CD44 antibody (Thermo Fisher, 156-3C11) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3a). PLoS ONE (2016) ncbi
mouse monoclonal (156-3C11)
  • immunocytochemistry; human; loading ...; fig 1d
  • western blot; human; loading ...; fig 2b
In order to investigate the roles of CD44v3 and CD44v6 in endocrine-resistant breast cancer, Invitrogen CD44 antibody (Thermo Fisher Scientific, 156-3C11) was used in immunocytochemistry on human samples (fig 1d) and in western blot on human samples (fig 2b). Front Oncol (2016) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry; human; fig 1
In order to analyze the impact of breast cancer stem cell marker expression on clinical outcome and trastuzumab response in human epidermal growth factor receptor 2-positive breast cancer, Invitrogen CD44 antibody (Thermo Fisher Scientific, 156-3C11) was used in immunohistochemistry on human samples (fig 1). Br J Cancer (2016) ncbi
mouse monoclonal (156-3C11)
  • flow cytometry; human; 1:200; fig 3
In order to characterize colonic cells treated with 4-methylnitrosamino-1-3-pyridyl-1-butanone, Invitrogen CD44 antibody (Thermo, MS-668) was used in flow cytometry on human samples at 1:200 (fig 3). Oncotarget (2016) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry; human; fig 1
In order to assess CD44 expression in different grades of mucoepidermoid carcinoma, Invitrogen CD44 antibody (Thermo Scientific, 156-3C11) was used in immunohistochemistry on human samples (fig 1). Head Face Med (2016) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry; human; 1:100; fig e5
In order to study triple-negative breast cancer and BET bromodomain inhibitor response and resistance, Invitrogen CD44 antibody (NeoMarkers, MS-668-P1) was used in immunohistochemistry on human samples at 1:100 (fig e5). Nature (2016) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to examine CD44 and MMP-9 expression in different ulcerative colitis lesions, Invitrogen CD44 antibody (Thermo-Lab Vision, 156-3C11) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Ann Diagn Pathol (2015) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:100-1:200; fig 2
In order to discuss thymic involution, Invitrogen CD44 antibody (Thermo Scientific, 156-3C11) was used in immunohistochemistry - paraffin section on human samples at 1:100-1:200 (fig 2). Int J Clin Exp Pathol (2015) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry; human; 1:25
In order to evaluate the expression of CD24, CD44, CD133 and ALDH1 in invasive ductal carcinoma of the breast, Invitrogen CD44 antibody (Thermo-Labvision, MS-668-R7) was used in immunohistochemistry on human samples at 1:25. Pathol Res Pract (2015) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human
In order to study the breast tumor microenvironment and interleukin-6 and pro inflammatory status, Invitrogen CD44 antibody (Neomarkers, 156-3C11) was used in immunohistochemistry - paraffin section on human samples . World J Surg Oncol (2015) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry; human; fig 9
In order to study promotion of collective invasion by an epigenetically distinct breast cancer cell subpopulation, Invitrogen CD44 antibody (Thermo Fisher Scientific, 156-3C11) was used in immunohistochemistry on human samples (fig 9). J Clin Invest (2015) ncbi
mouse monoclonal (156-3C11)
  • immunocytochemistry; human; 4 ug/ml
In order to determine the role of CD9 in adhesion, migration and invasiveness of breast cancer cells, Invitrogen CD44 antibody (ThermoScientific, MA5-13890) was used in immunocytochemistry on human samples at 4 ug/ml. Oncotarget (2015) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:2000; tbl 2
In order to identify biomarkers using HER2-positive advanced breast cancer samples from patients treated with trastuzumab and paclitaxel combination chemotherapy, Invitrogen CD44 antibody (Thermo Fisher Scientific, 156-3C11) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (tbl 2). Tumour Biol (2015) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to assess the diagnostic role of CD44 and E-cadherin in atypical leiomyoma and leiomyosarcoma, Invitrogen CD44 antibody (Thermo Scientific, 156-3C11) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). J Obstet Gynaecol (2015) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; tbl 3
In order to study miR-9, and miR-155 expression in breast cancer and how their expression correlates with different features of breast cancer, Invitrogen CD44 antibody (Thermo Scientific, 156-3C11) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 3). Breast Cancer Res Treat (2014) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:100
In order to identify diagnostic and prognostic markers for glioblastoma, Invitrogen CD44 antibody (Lab Vision, MS-668) was used in immunohistochemistry - paraffin section on human samples at 1:100. Int J Oncol (2012) ncbi
Articles Reviewed
  1. Ramos E, Tsai C, Jia Y, Cao Y, Manu M, Taftaf R, et al. Machine learning-assisted elucidation of CD81-CD44 interactions in promoting cancer stemness and extracellular vesicle integrity. elife. 2022;11: pubmed publisher
  2. Xiao L, Mochizuki M, Nakahara T, Miwa N. Hydrogen-Generating Silica Material Prevents UVA-ray-Induced Cellular Oxidative Stress, Cell Death, Collagen Loss and Melanogenesis in Human Cells and 3D Skin Equivalents. Antioxidants (Basel). 2021;10: pubmed publisher
  3. Moreno Rodríguez M, Perez S, Nadeem M, Malek Ahmadi M, Mufson E. Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer's disease. J Neuroinflammation. 2020;17:58 pubmed publisher
  4. Sang Y, Li Y, Zhang Y, Alvarez A, Yu B, Zhang W, et al. CDK5-dependent phosphorylation and nuclear translocation of TRIM59 promotes macroH2A1 ubiquitination and tumorigenicity. Nat Commun. 2019;10:4013 pubmed publisher
  5. Chang Y, Lin T, Campbell M, Pan C, Lee S, Lee H, et al. REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer. Sci Rep. 2017;7:42795 pubmed publisher
  6. Horvatinovich J, Grogan E, Norris M, Steinkasserer A, Lemos H, Mellor A, et al. Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes. J Immunol. 2017;198:2286-2301 pubmed publisher
  7. Yoo S, Leng L, Kim B, Du X, Tilstam P, Kim K, et al. MIF allele-dependent regulation of the MIF coreceptor CD44 and role in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2016;113:E7917-E7926 pubmed
  8. Zhao H, Tang H, Xiao Q, He M, Zhao L, Fu Y, et al. The Hedgehog signaling pathway is associated with poor prognosis in breast cancer patients with the CD44+/CD24? phenotype. Mol Med Rep. 2016;14:5261-5270 pubmed publisher
  9. Horimoto Y, Arakawa A, Sasahara N, Tanabe M, Sai S, Himuro T, et al. Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases. PLoS ONE. 2016;11:e0165253 pubmed publisher
  10. Bellerby R, Smith C, Kyme S, Gee J, Gunthert U, Green A, et al. Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance. Front Oncol. 2016;6:145 pubmed publisher
  11. Seo A, Lee H, Kim E, Jang M, Kim Y, Kim J, et al. Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer. Br J Cancer. 2016;114:1109-16 pubmed publisher
  12. Lee T, Liu C, Chang Y, Nieh S, Lin Y, Jao S, et al. Increased chemoresistance via Snail-Raf kinase inhibitor protein signaling in colorectal cancer in response to a nicotine derivative. Oncotarget. 2016;7:23512-20 pubmed publisher
  13. Binmadi N, Elsissi A, Elsissi N. Expression of cell adhesion molecule CD44 in mucoepidermoid carcinoma and its association with the tumor behavior. Head Face Med. 2016;12:8 pubmed publisher
  14. Shu S, Lin C, He H, Witwicki R, Tabassum D, Roberts J, et al. Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer. Nature. 2016;529:413-417 pubmed publisher
  15. AbdElazeem M, El Sayed M. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia. Ann Diagn Pathol. 2015;19:369-74 pubmed publisher
  16. Ceyran A, Şenol S, Güzelmeriç F, Tunçer E, Tongut A, Özbek B, et al. Effects of hypoxia and its relationship with apoptosis, stem cells, and angiogenesis on the thymus of children with congenital heart defects: a morphological and immunohistochemical study. Int J Clin Exp Pathol. 2015;8:8038-47 pubmed
  17. KapucuoÄŸlu N, Bozkurt K, BaÅŸpınar Å, Koçer M, EroÄŸlu H, Akdeniz R, et al. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer. Pathol Res Pract. 2015;211:740-7 pubmed publisher
  18. Sanguinetti A, Santini D, Bonafè M, Taffurelli M, Avenia N. Interleukin-6 and pro inflammatory status in the breast tumor microenvironment. World J Surg Oncol. 2015;13:129 pubmed publisher
  19. Westcott J, Prechtl A, Maine E, Dang T, Esparza M, Sun H, et al. An epigenetically distinct breast cancer cell subpopulation promotes collective invasion. J Clin Invest. 2015;125:1927-43 pubmed publisher
  20. Rappa G, Green T, Karbanová J, Corbeil D, Lorico A. Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells. Oncotarget. 2015;6:7970-91 pubmed
  21. Koo D, Lee H, Ahn J, Yoon D, Kim S, Gong G, et al. Tau and PTEN status as predictive markers for response to trastuzumab and paclitaxel in patients with HER2-positive breast cancer. Tumour Biol. 2015;36:5865-71 pubmed publisher
  22. Kaygusuz E. Immunohistochemical expression of CD44 standard and E-cadherin in atypical leiomyoma and leiomyosarcoma of the uterus. J Obstet Gynaecol. 2015;35:279-82 pubmed publisher
  23. Gwak J, Kim H, Kim E, Chung Y, Yun S, Seo A, et al. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. Breast Cancer Res Treat. 2014;147:39-49 pubmed publisher
  24. Jung Y, Joo K, Seong D, Choi Y, Kong D, Kim Y, et al. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Int J Oncol. 2012;40:1122-32 pubmed publisher